Skip to main content
Top
Published in: Heart and Vessels 10/2021

Open Access 01-10-2021 | Heart Failure | Original Article

Predictors of functional mitral regurgitation recurrence after percutaneous mitral valve repair

Authors: Katharina Hellhammer, Jean M. Haurand, Maximilian Spieker, Peter Luedike, Tienush Rassaf, Tobias Zeus, Malte Kelm, Ralf Westenfeld, Patrick Horn

Published in: Heart and Vessels | Issue 10/2021

Login to get access

Abstract

We aimed to identify predictors of mitral regurgitation recurrence (MR) after percutaneous mitral valve repair (PMVR) in patients with functional mitral regurgitation (FMR). Patients with FMR were enrolled who underwent PMVR using the MitraClip® device. Procedural success was defined as reduction of MR of at least one grade to MR grade ≤ 2 + assessed at discharge. Recurrence of MR was defined as MR grade 3 + or worse at one year after initially successful PMVR. A total of 306 patients with FMR underwent PMVR procedure. In 279 out of 306 patients (91.2%), PMVR was successfully performed with MR grade ≤ 2 + at discharge. In 11.4% of these patients, MR recurrence of initial successful PMVR after 1 year was observed. Recurrence of MR was associated with a higher rate of heart failure rehospitalization during the 12 months follow-up (52.0% vs. 30.3%; p = 0.029), and less improvement in New York Heart Association (NYHA) functional class [68% vs. 19% of the patients presenting with NYHA functional class III or IV one year after PMVR when compared to patients without recurrence (p = 0.001)]. Patients with MR recurrence were characterized by a higher left ventricular sphericity index {0.69 [Interquartile range (IQR) 0.64, 0.74] vs. 0.65 (IQR 0.58, 0.70), p = 0.003}, a larger left atrium volume [118 (IQR 96, 143) ml vs. 102 (IQR 84, 123) ml, p = 0.019], a larger tenting height 10 (IQR 9, 13) mm vs. 8 (IQR 7, 11) mm (p = 0.047), and a larger mitral valve annulus [41 (IQR 38, 43) mm vs. 39 (IQR 36, 40) mm, p = 0.015] when compared to patients with durable optimal long-term results. In a multivariate regression model, the left ventricular sphericity index [Odds Ratio (OR) 1.120, 95% Confidence Interval (CI) 1.039–1.413, p = 0.003)], tenting height (OR 1.207, 95% CI 1.031–1.413, p = 0.019), and left atrium enlargement (OR 1.018, 95% CI 1.000–1.038, p = 0.047) were predictors for MR recurrence after 1 year. In patients with FMR, baseline parameters of advanced heart failure such as spherical ventricle, tenting height and a large left atrium might indicate risk of recurrent MR one year after PMVR.
Literature
1.
go back to reference Goliasch G, Bartko PE, Pavo N, Neuhold S, Wurm R, Mascherbauer J, Lang IM, Strunk G, Hulsmann M (2018) Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur Heart J 39:39–46CrossRef Goliasch G, Bartko PE, Pavo N, Neuhold S, Wurm R, Mascherbauer J, Lang IM, Strunk G, Hulsmann M (2018) Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur Heart J 39:39–46CrossRef
2.
go back to reference Di Mauro M, Gallina S, D’Amico MA, Izzicupo P, Lanuti P, Bascelli A, Di Fonso A, Bartoloni G, Calafiore AM, Di Baldassarre A, Italian Group of Study for Heart Valve D (2013) Functional mitral regurgitation: from normal to pathological anatomy of mitral valve. Int J Cardiol 163:242–248CrossRef Di Mauro M, Gallina S, D’Amico MA, Izzicupo P, Lanuti P, Bascelli A, Di Fonso A, Bartoloni G, Calafiore AM, Di Baldassarre A, Italian Group of Study for Heart Valve D (2013) Functional mitral regurgitation: from normal to pathological anatomy of mitral valve. Int J Cardiol 163:242–248CrossRef
3.
go back to reference Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D’Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O’Gara PT, Michler RE, Kron IL, Ctsn (2014) Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 370:23–32 Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D’Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O’Gara PT, Michler RE, Kron IL, Ctsn (2014) Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 370:23–32
4.
go back to reference Ciarka A, Braun J, Delgado V, Versteegh M, Boersma E, Klautz R, Dion R, Bax JJ, Van de Veire N (2010) Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol 106:395–401CrossRef Ciarka A, Braun J, Delgado V, Versteegh M, Boersma E, Klautz R, Dion R, Bax JJ, Van de Veire N (2010) Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am J Cardiol 106:395–401CrossRef
5.
go back to reference Reichart D, Kalbacher D, Rubsamen N, Tigges E, Thomas C, Schirmer J, Reichenspurner H, Blankenberg S, Conradi L, Schafer U, Lubos E (2020) The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitation. Eur J Heart Fail 22(10):1840–1848CrossRef Reichart D, Kalbacher D, Rubsamen N, Tigges E, Thomas C, Schirmer J, Reichenspurner H, Blankenberg S, Conradi L, Schafer U, Lubos E (2020) The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitation. Eur J Heart Fail 22(10):1840–1848CrossRef
6.
go back to reference Kaneko H, Neuss M, Weissenborn J, Butter C (2017) Impact of residual mitral regurgitation after MitraClip implantation. Int J Cardiol 227:813–819CrossRef Kaneko H, Neuss M, Weissenborn J, Butter C (2017) Impact of residual mitral regurgitation after MitraClip implantation. Int J Cardiol 227:813–819CrossRef
7.
go back to reference Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefevre T, Piot C, Rouleau F, Carrie D, Nejjari M, Ohlmann P, Leclercq F, Saint Etienne C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N, Investigators M-F (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 379:2297–2306 Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefevre T, Piot C, Rouleau F, Carrie D, Nejjari M, Ohlmann P, Leclercq F, Saint Etienne C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N, Investigators M-F (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 379:2297–2306
8.
go back to reference Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ, Investigators C (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379:2307–2318CrossRef Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ, Investigators C (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379:2307–2318CrossRef
9.
go back to reference Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr 30:303–371CrossRef Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr 30:303–371CrossRef
10.
go back to reference Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Group ESCSD (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Group ESCSD (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef
11.
go back to reference Horn P, Hellhammer K, Minier M, Stenzel MA, Veulemans V, Rassaf T, Luedike P, Pohl J, Balzer J, Zeus T, Kelm M, Westenfeld R (2017) Deep sedation vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip((R)) system. Catheter Cardiovasc Interv 90:1212–1219CrossRef Horn P, Hellhammer K, Minier M, Stenzel MA, Veulemans V, Rassaf T, Luedike P, Pohl J, Balzer J, Zeus T, Kelm M, Westenfeld R (2017) Deep sedation vs. general anesthesia in 232 patients undergoing percutaneous mitral valve repair using the MitraClip((R)) system. Catheter Cardiovasc Interv 90:1212–1219CrossRef
12.
go back to reference Stone GW, Adams DH, Abraham WT, Kappetein AP, Genereux P, Vranckx P, Mehran R, Kuck KH, Leon MB, Piazza N, Head SJ, Filippatos G, Vahanian AS, Mitral Valve Academic Research C (2015) Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol 66:308–321CrossRef Stone GW, Adams DH, Abraham WT, Kappetein AP, Genereux P, Vranckx P, Mehran R, Kuck KH, Leon MB, Piazza N, Head SJ, Filippatos G, Vahanian AS, Mitral Valve Academic Research C (2015) Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol 66:308–321CrossRef
13.
go back to reference Ailawadi G, Lim DS, Mack MJ, Trento A, Kar S, Grayburn PA, Glower DD, Wang A, Foster E, Qasim A, Weissman NJ, Ellis J, Crosson L, Fan F, Kron IL, Pearson PJ, Feldman T, Investigators EI (2019) One-year outcomes after MitraClip for functional mitral regurgitation. Circulation 139:37–47CrossRef Ailawadi G, Lim DS, Mack MJ, Trento A, Kar S, Grayburn PA, Glower DD, Wang A, Foster E, Qasim A, Weissman NJ, Ellis J, Crosson L, Fan F, Kron IL, Pearson PJ, Feldman T, Investigators EI (2019) One-year outcomes after MitraClip for functional mitral regurgitation. Circulation 139:37–47CrossRef
14.
go back to reference Pighi M, Estevez-Loureiro R, Maisano F, Ussia GP, Dall’Ara G, Franzen O, Laroche C, Settergren M, Winter R, Nickenig G, Gilard M, Di Mario C, Transcatheter Valve Treatment Sentinel Registry Investigators of the ERPotESoC (2017) Immediate and 12 month outcomes of ischemic versus nonischemic functional mitral regurgitation in patients treated with MitraClip (from the 2011 to 2012 pilot sentinel registry of percutaneous edge-to-edge mitral valve repair of the European society of cardiology). Am J Cardiol 119:630–637CrossRef Pighi M, Estevez-Loureiro R, Maisano F, Ussia GP, Dall’Ara G, Franzen O, Laroche C, Settergren M, Winter R, Nickenig G, Gilard M, Di Mario C, Transcatheter Valve Treatment Sentinel Registry Investigators of the ERPotESoC (2017) Immediate and 12 month outcomes of ischemic versus nonischemic functional mitral regurgitation in patients treated with MitraClip (from the 2011 to 2012 pilot sentinel registry of percutaneous edge-to-edge mitral valve repair of the European society of cardiology). Am J Cardiol 119:630–637CrossRef
15.
go back to reference Taramasso M, Denti P, Latib A, Guidotti A, Buzzatti N, Pozzoli A, Di Giannuario G, La Canna G, Colombo A, Alfieri O, Maisano F (2015) Clinical and anatomical predictors of MitraClip therapy failure for functional mitral regurgitation: single central clip strategy in asymmetric tethering. Int J Cardiol 186:286–288CrossRef Taramasso M, Denti P, Latib A, Guidotti A, Buzzatti N, Pozzoli A, Di Giannuario G, La Canna G, Colombo A, Alfieri O, Maisano F (2015) Clinical and anatomical predictors of MitraClip therapy failure for functional mitral regurgitation: single central clip strategy in asymmetric tethering. Int J Cardiol 186:286–288CrossRef
16.
go back to reference De Bonis M, Lapenna E, Buzzatti N, La Canna G, Denti P, Pappalardo F, Schiavi D, Pozzoli A, Cioni M, Di Giannuario G, Alfieri O (2016) Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years? Eur J Cardiothorac Surg 50:488–494CrossRef De Bonis M, Lapenna E, Buzzatti N, La Canna G, Denti P, Pappalardo F, Schiavi D, Pozzoli A, Cioni M, Di Giannuario G, Alfieri O (2016) Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years? Eur J Cardiothorac Surg 50:488–494CrossRef
17.
go back to reference Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, Zuern CS, Bekeredjian R, Sievert H, Nickenig G, Eggebrecht H, Senges J, Schillinger W (2016) One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J 37:703–712 Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, Zuern CS, Bekeredjian R, Sievert H, Nickenig G, Eggebrecht H, Senges J, Schillinger W (2016) One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J 37:703–712
18.
go back to reference Cuspidi C, Tadic M, Sala C (2017) Beyond left ventricular mass: the prognostic power of left ventricular shape. Heart 103:481–482CrossRef Cuspidi C, Tadic M, Sala C (2017) Beyond left ventricular mass: the prognostic power of left ventricular shape. Heart 103:481–482CrossRef
19.
go back to reference Lavie CJ, Patel DA, Milani RV, Ventura HO, Shah S, Gilliland Y (2014) Impact of echocardiographic left ventricular geometry on clinical prognosis. Prog Cardiovasc Dis 57:3–9CrossRef Lavie CJ, Patel DA, Milani RV, Ventura HO, Shah S, Gilliland Y (2014) Impact of echocardiographic left ventricular geometry on clinical prognosis. Prog Cardiovasc Dis 57:3–9CrossRef
20.
go back to reference Ambale-Venkatesh B, Yoneyama K, Sharma RK, Ohyama Y, Wu CO, Burke GL, Shea S, Gomes AS, Young AA, Bluemke DA, Lima JA (2017) Left ventricular shape predicts different types of cardiovascular events in the general population. Heart 103:499–507CrossRef Ambale-Venkatesh B, Yoneyama K, Sharma RK, Ohyama Y, Wu CO, Burke GL, Shea S, Gomes AS, Young AA, Bluemke DA, Lima JA (2017) Left ventricular shape predicts different types of cardiovascular events in the general population. Heart 103:499–507CrossRef
21.
go back to reference Capodanno D, Adamo M, Barbanti M, Giannini C, Laudisa ML, Cannata S, Curello S, Imme S, Maffeo D, Bedogni F, Petronio AS, Ettori F, Tamburino C, Grasso C, InvestigatorsG-I (2015) Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. Am Heart J 170:187–195CrossRef Capodanno D, Adamo M, Barbanti M, Giannini C, Laudisa ML, Cannata S, Curello S, Imme S, Maffeo D, Bedogni F, Petronio AS, Ettori F, Tamburino C, Grasso C, InvestigatorsG-I (2015) Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. Am Heart J 170:187–195CrossRef
22.
go back to reference De Bonis M, Al-Attar N, Antunes M, Borger M, Casselman F, Falk V, Folliguet T, Iung B, Lancellotti P, Lentini S, Maisano F, Messika-Zeitoun D, Muneretto C, Pibarot P, Pierard L, Punjabi P, Rosenhek R, Suwalski P, Vahanian A, Wendler O, Prendergast B (2016) Surgical and interventional management of mitral valve regurgitation: a position statement from the European society of cardiology working groups on cardiovascular surgery and valvular heart disease. Eur Heart J 37:133–139CrossRef De Bonis M, Al-Attar N, Antunes M, Borger M, Casselman F, Falk V, Folliguet T, Iung B, Lancellotti P, Lentini S, Maisano F, Messika-Zeitoun D, Muneretto C, Pibarot P, Pierard L, Punjabi P, Rosenhek R, Suwalski P, Vahanian A, Wendler O, Prendergast B (2016) Surgical and interventional management of mitral valve regurgitation: a position statement from the European society of cardiology working groups on cardiovascular surgery and valvular heart disease. Eur Heart J 37:133–139CrossRef
23.
go back to reference Mandegar MH, Saidi B, Yousefnia MA, Alaeddini F, Roshanali F (2011) Long-term effect of papillary muscle approximation combined with ventriculoplasty on left ventricle function in patients with ischemic cardiomyopathy and functional mitral regurgitation. Eur J Cardiothorac Surg 40:756–760PubMed Mandegar MH, Saidi B, Yousefnia MA, Alaeddini F, Roshanali F (2011) Long-term effect of papillary muscle approximation combined with ventriculoplasty on left ventricle function in patients with ischemic cardiomyopathy and functional mitral regurgitation. Eur J Cardiothorac Surg 40:756–760PubMed
24.
go back to reference Jorapur V, Voudouris A, Lucariello RJ (2005) Quantification of annular dilatation and papillary muscle separation in functional mitral regurgitation: role of anterior mitral leaflet length as reference. Echocardiography 22:465–472CrossRef Jorapur V, Voudouris A, Lucariello RJ (2005) Quantification of annular dilatation and papillary muscle separation in functional mitral regurgitation: role of anterior mitral leaflet length as reference. Echocardiography 22:465–472CrossRef
25.
go back to reference Stolfo D, De Luca A, Morea G, Merlo M, Vitrella G, Caiffa T, Barbati G, Rakar S, Korcova R, Perkan A, Pinamonti B, Pappalardo A, Berardini A, Biagini E, Saia F, Grigioni F, Rapezzi C, Sinagra G (2018) Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection. Int J Cardiol 257:182–187CrossRef Stolfo D, De Luca A, Morea G, Merlo M, Vitrella G, Caiffa T, Barbati G, Rakar S, Korcova R, Perkan A, Pinamonti B, Pappalardo A, Berardini A, Biagini E, Saia F, Grigioni F, Rapezzi C, Sinagra G (2018) Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection. Int J Cardiol 257:182–187CrossRef
26.
go back to reference Dziadzko V, Dziadzko M, Medina-Inojosa JR, Benfari G, Michelena HI, Crestanello JA, Maalouf J, Thapa P, Enriquez-Sarano M (2019) Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur Heart J 40:2194–2202CrossRef Dziadzko V, Dziadzko M, Medina-Inojosa JR, Benfari G, Michelena HI, Crestanello JA, Maalouf J, Thapa P, Enriquez-Sarano M (2019) Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome. Eur Heart J 40:2194–2202CrossRef
27.
go back to reference Di Tullio MR, Qian M, Thompson JLP, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GYH, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S, Investigators W (2018) Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. ESC Heart Fail 5:800–808CrossRef Di Tullio MR, Qian M, Thompson JLP, Labovitz AJ, Mann DL, Sacco RL, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Lip GYH, Levin B, Mohr JP, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Homma S, Investigators W (2018) Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. ESC Heart Fail 5:800–808CrossRef
28.
go back to reference Iliadis C, Baldus S, Kalbacher D, Boekstegers P, Schillinger W, Ouarrak T, Zahn R, Butter C, Zuern CS, von Bardeleben RS, Senges J, Bekeredjian R, Eggebrecht H, Pfister R (2020) Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry. Eur J Heart Fail 22(7):1202–1210CrossRef Iliadis C, Baldus S, Kalbacher D, Boekstegers P, Schillinger W, Ouarrak T, Zahn R, Butter C, Zuern CS, von Bardeleben RS, Senges J, Bekeredjian R, Eggebrecht H, Pfister R (2020) Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry. Eur J Heart Fail 22(7):1202–1210CrossRef
29.
go back to reference Le Bihan DC, Della Togna DJ, Barretto RB, Assef JE, Machado LR, Ramos AI, Abdulmassih Neto C, Moises VA, Sousa AG, Campos O (2015) Early improvement in left atrial remodeling and function after mitral valve repair or replacement in organic symptomatic mitral regurgitation assessed by three-dimensional echocardiography. Echocardiography 32:1122–1130CrossRef Le Bihan DC, Della Togna DJ, Barretto RB, Assef JE, Machado LR, Ramos AI, Abdulmassih Neto C, Moises VA, Sousa AG, Campos O (2015) Early improvement in left atrial remodeling and function after mitral valve repair or replacement in organic symptomatic mitral regurgitation assessed by three-dimensional echocardiography. Echocardiography 32:1122–1130CrossRef
30.
go back to reference Messika-Zeitoun D, Nickenig G, Latib A, Kuck KH, Baldus S, Schueler R, La Canna G, Agricola E, Kreidel F, Huntgeburth M, Zuber M, Verta P, Grayburn P, Vahanian A, Maisano F (2019) Transcatheter mitral valve repair for functional mitral regurgitation using the cardioband system: 1 year outcomes. Eur Heart J 40:466–472CrossRef Messika-Zeitoun D, Nickenig G, Latib A, Kuck KH, Baldus S, Schueler R, La Canna G, Agricola E, Kreidel F, Huntgeburth M, Zuber M, Verta P, Grayburn P, Vahanian A, Maisano F (2019) Transcatheter mitral valve repair for functional mitral regurgitation using the cardioband system: 1 year outcomes. Eur Heart J 40:466–472CrossRef
Metadata
Title
Predictors of functional mitral regurgitation recurrence after percutaneous mitral valve repair
Authors
Katharina Hellhammer
Jean M. Haurand
Maximilian Spieker
Peter Luedike
Tienush Rassaf
Tobias Zeus
Malte Kelm
Ralf Westenfeld
Patrick Horn
Publication date
01-10-2021
Publisher
Springer Japan
Keyword
Heart Failure
Published in
Heart and Vessels / Issue 10/2021
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-021-01828-9

Other articles of this Issue 10/2021

Heart and Vessels 10/2021 Go to the issue